APP and Alzheimer disease: Lopez-Rodriguez et al. (2021) [27] utilized APP/PS1 double transgenic mouse models to demonstrate that microglia and astrocytes in the AD brain are primed, exhibiting exaggerated inflammatory responses to acute peripheral lipopolysaccharide (LPS) challenge.